Ingredion Incorporated reported Q2 2026 results with reported diluted EPS of $1.78 and adjusted EPS of $2.82, down from $2.99 and $2.87 respectively in Q2 2025. Net sales increased 1% to $1.85 billion, while adjusted operating income declined 5%. The company completed the sale of its Pakistan business majority stake and announced that Tate & Lyle shareholders approved its 595 pence all-cash acquisition offer. Ingredion reaffirmed full-year 2026 guidance with reported EPS of $9.15-$9.75 and adjusted EPS of $10.30-$10.90.

Ingredion Incorporated reported Q2 2026 results showing a 31% decline in reported operating income and 5% decline in adjusted operating income year-over-year, with diluted EPS of $1.78 (reported) and $2.82 (adjusted). The company successfully sold a majority stake in its Pakistan business and received shareholder approval from Tate & Lyle for its 595 pence all-cash acquisition offer. Despite operational challenges at the Argo plant, the Texture & Healthful Solutions segment showed nine consecutive quarters of net volume growth. Full-year 2026 guidance was maintained with expected reported EPS of $9.15-$9.75 and adjusted EPS of $10.30-$10.90.

Ingredion Incorporated reported Q2 2026 results with reported diluted EPS of $1.78 versus $2.99 in Q2 2025, representing a 40% decline. The company reaffirmed full-year 2026 guidance with adjusted EPS expected between $10.30-$10.90. Notably, Tate & Lyle shareholders approved Ingredion's £595 pence per share all-cash acquisition offer on July 28, 2026, marking a significant step toward completing the transaction.

The global protein ingredients market is projected to grow from USD 83.14 billion in 2026 to USD 121.53 billion by 2031, with a CAGR of 7.9%. Europe leads with 33.3% market share, while South America shows fastest regional growth. Insect-based proteins are the fastest-growing segment due to sustainability benefits. Key players include ADM, Cargill, Kerry Group, and Roquette, with recent product launches and partnerships driving innovation in plant-based and alternative proteins.

The global confectionery ingredients market is projected to grow from $89.2 billion in 2025 to $117.7 billion by 2030 at a 5.7% CAGR. Growth is driven by rapid urbanization, e-commerce expansion, and consumer demand for health-conscious, clean-label products. Asia-Pacific leads with 29.8% market share, while major players leverage AI and sustainable technologies for innovation.

Ingredion Incorporated announced a recommended all-cash acquisition of Tate & Lyle PLC for approximately 3.7 billion pounds sterling (5 billion USD). The transaction aims to create a global specialty ingredients leader by combining complementary ingredient portfolios, expanding capabilities in texturants, sugar reduction, and nutritional enrichment, and diversifying geographic supply networks. The deal is expected to generate annual cost synergies of approximately 130 million USD by end of 2030 and be accretive to adjusted EPS in the first year post-closing.

Ingredion Incorporated announced a recommended all-cash acquisition of Tate & Lyle PLC for approximately 3.7 billion GBP (5.0 billion USD). The merger aims to create a global leader in specialty ingredient solutions by combining complementary portfolios in texturization, sugar reduction, and nutritional enrichment. The deal is expected to generate approximately 130 million USD in annual cost synergies by end of 2030 and is projected to be accretive to Ingredion's adjusted earnings per share in the first year post-closing.

U.S. stock futures showed mixed performance on Monday with the S&P 500 and Nasdaq 100 gaining while the Dow Jones fell, following Thursday's sharp declines. Geopolitical tensions escalated over the weekend as Iran and Israel exchanged missile strikes. Key stocks in focus included SK Telecom (partnership with Nvidia), Nebius (UK AI data center investment), AMD (UK AI investment), and Ingredion (acquisition by Tate & Lyle). Markets are pricing in a 98% likelihood of unchanged Fed rates in June.

Ingredion announced a $5 billion all-cash acquisition of Tate & Lyle, expanding its specialty ingredients portfolio. The deal is expected to generate $130 million in annual cost synergies by 2030 and close in H2 2027. However, INGR stock traded lower in premarket, down 0.98% to $99.00, as it remains in a longer-term downtrend trading below key moving averages.

Ingredion Incorporated announced a recommended all-cash acquisition of Tate & Lyle PLC for approximately £3.7B ($5.0B), or 595 pence per share, representing a 59% premium to Tate & Lyle's closing price as of May 13, 2026. The combined entity aims to create a global leader in specialty ingredient solutions with complementary portfolios in texturants, sugar reduction, and fortification. The deal is expected to deliver approximately $130 million in annual run-rate net cost synergies by end of 2030 and be adjusted EPS accretive in the first year post-completion. Completion is expected in the second half of 2027, subject to regulatory approvals and Tate & Lyle shareholder approval.

Ingredion Incorporated announced the acquisition of Benicaros®, a patented prebiotic fiber made from upcycled carrot pomace that supports immune health at low dosages. The product is water-soluble, plant-based, and addresses limitations of traditional prebiotic fibers. The acquisition includes full ownership of intellectual property, trademarks, clinical trials, and manufacturing know-how.

The global juice concentrates market was valued at USD 84.9 billion in 2025 and is projected to grow at a 5% CAGR to reach USD 138.3 billion by 2035. Growth is driven by increasing consumer demand for nutritious, convenient beverages and natural products. Fruit juice concentrates dominate with 69% market share, while vacuum concentration technology holds 48.5% share. North America accounts for 20% of the market, with key players investing in innovation, sustainable sourcing, and advanced processing technologies.